Find A Physician
Return to Artificial Heart - Ventricular Assist Devices (VADs) Overview
More on Artificial Heart - Ventricular Assist Devices (VADs)
Hospital News
Return to Artificial Heart - Ventricular Assist Devices (VADs) Overview
More on Artificial Heart - Ventricular Assist Devices (VADs)
- Lessons From Major Heart Trial Need Implementation
- The PARTNER Trial Shows Similar One-Year Survival for Catheter-Based Aortic Valve Replacement and Open Aortic Valve Replacement in High-Risk Patients
- Bariatric Surgery Reduces Long-Term Cardiovascular Risk in Diabetes Patients
- Barbara Walters Heart Health Special
- Blood Test to Predict Multi-Organ Dysfunction in Patients With LVADs on Horizon
- Gene Therapy Can Substantially Improve Outcomes for Some Patients With Advanced Heart Failure
- Cooling May Benefit Children After Cardiac Arrest
- Gene Expression Test Reduces Need for Invasive Heart Muscle Biopsy
- Women's Health Alert: Fighting Heart Disease in Your 40s
- Dr. Craig R. Smith Named Chair of Surgery and Surgeon-in-Chief at Columbia University Medical Center and NewYork-Presbyterian/Columbia
- Ronald O. Perelman Heart Institute of NewYork-Presbyterian Hospital/Weill Cornell Medical Center Opens as a Center for Innovative, World-Class Cardiac Care and Patient Education
- 100th Heart Valve Replacement Implanted Without Open-Heart Surgery at NewYork-Presbyterian/Columbia
- First Heart Patients Implanted With Next-Generation Mechanical Heart Pump
- NEJM Study Finds Drug-Eluting Stents More Effective Than Bare-Metal Stents in Heart Attack Patients
- Potential Lung Disease Biomarkers Yield Clues to COX-2 Inhibitor Side Effects
- Unique Cardiac Training Gives NewYork-Presbyterian/Columbia Doctor Ability to Treat Heart Patients With Hybrid Approach
Research and Clinical Trials
Return to Artificial Heart - Ventricular Assist Devices (VADs) Overview
More on Artificial Heart - Ventricular Assist Devices (VADs)
Health Library
Return to Artificial Heart - Ventricular Assist Devices (VADs) Overview
More on Artificial Heart - Ventricular Assist Devices (VADs)
Clinical Services
Return to Artificial Heart - Ventricular Assist Devices (VADs) Overview
More on Artificial Heart - Ventricular Assist Devices (VADs)
- Adult Congenital Heart Disease
- Adult Congenital Heart Disease Surgery
- Advanced Diagnostics
- Alcohol Septal Ablation
- Angiograms
- Angioplasty and Stenting
- Arrhythmia Control
- Balloon Valvuloplasty for Heart Valve Disease
- Bridge to Transplant
- Cardiac Electrophysiologic Studies
- Cardiac Magnetic Resonance Imaging (MRI)
- Cardiac Rehabilitation
- Cardiology
- Cardiothoracic Surgery
- Catheter Ablation for Cardiac Arrhythmias
- Coronary Artery Bypass Surgery (CABG)
- Destination Therapy
- Echocardiograms
- Electrocardiograms (ECGs), Stress Tests, Holter Monitor and Event/Loop Recorders
- Heart Attack Care
- Heart Attacks in Women
- Heart Transplant Surgery
- Heart Valve Repair and Replacement
- Heart Valve Replacement Studies and Clinical Trials
- Heart Valve Treatments
- Implantable Converter Defibrillators and Biventricular Pacing
- Intravascular / Intracoronary and Intracardiac Ultrasound
- Nuclear Imaging For Heart Disease (PET scans, MUGA scans)
- Off-Pump Surgery
- Pacemakers
- Pediatric Heart Surgery
- Prevention
- Preventive Cardiology
- Preventive Medicine and Nutrition
- Risk Factors for Heart Attacks
- Robotic Heart Surgery
- Tilt Testing
- Transmyocardial Revascularization
- Treating a Heart Attack
- Treatment of Peripheral Arterial Disease
- Warning Signs
- What is Heart Failure?
Cardiothoracic Surgery
Artificial Heart - Ventricular Assist Devices (VADs)
Back to the nypheart.org Home Page
Mechanical Circulatory Support at NewYork-Presbyterian Hospital
More than 500,000 people are diagnosed with heart failure each year in the United States. Their hearts become too weak to efficiently pump blood to other parts of the body. Some patients benefit from drug therapy. But others may require a heart transplant or other intervention. When heart failure reaches this advanced stage, it can be life-threatening. NewYork-Presbyterian Hospital offers world-renowned care to help these patients live longer and enjoy a better quality of life
There are not enough donor hearts to meet the needs of all the patients who require them. Patients with end-stage heart failure may therefore benefit from mechanical cardiac assist devices, the most common of which are ventricular assist devices (VADs). These surgically implanted mechanical pumps can help:
- patients who are awaiting a heart transplant ("bridge to transplantation")
- patients who are not eligible for a transplant ("destination therapy").
NewYork-Presbyterian Hospital is a leader in the development and implantation of VADs for patients with heart failure. Why come to us for your care? Consider these facts:
- The Mechanical Circulatory Support Program at NewYork-Presbyterian Hospital/Columbia University Medical Center has been helping patients benefit from VADs since 1990 and performs one to two VAD implantations each week.
- More than 500 NewYork-Presbyterian Hospital patients have benefited from VADs to date, including more than 350 since 2006 alone.
- Patients being evaluated for VAD therapy may consult with a dedicated team of physicians and nurses at either NewYork-Presbyterian Hospital campus (Columbia University Medical Center or Weill Cornell Medical Center). Close collaboration between the two campuses ensures continuity of care.
Contact
- Cardiothoracic Surgery, NewYork-Presbyterian/Weill Cornell
-
Directions
(212) 746-5151
- Cardiothoracic Surgery, NewYork-Presbyterian/Columbia
-
Directions
(212) 305-8312
